Viewing Study NCT03732560


Ignite Creation Date: 2025-12-25 @ 2:13 AM
Ignite Modification Date: 2026-01-05 @ 12:52 PM
Study NCT ID: NCT03732560
Status: COMPLETED
Last Update Posted: 2022-12-08
First Post: 2018-11-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Comparison of Nivolumab-based Treatments in a Real-world PD-L1 Positive Metastatic Melanoma Population in the US
Sponsor: Bristol-Myers Squibb
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module